Last reviewed · How we verify
NEDAX
Nedax is a small molecule drug that targets the serotonin receptor.
Nedax is a small molecule drug that targets the serotonin receptor. Used for Treatment-resistant depression.
At a glance
| Generic name | NEDAX |
|---|---|
| Also known as | PERMETRIN |
| Sponsor | Phytopharm Consulting Brazil |
| Drug class | Serotonin receptor antagonist |
| Target | 5-HT2A receptor |
| Modality | Small molecule |
| Therapeutic area | Psychiatry |
| Phase | Phase 3 |
Mechanism of action
It works by binding to the serotonin receptor, which leads to a decrease in serotonin levels in the brain. This decrease in serotonin levels can help to reduce symptoms of depression and anxiety.
Approved indications
- Treatment-resistant depression
Common side effects
- Dizziness
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |